MATA NATHAN L. (Chief Scientific Officer) sold 17.6% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $157.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 5/1/2026ACC: 0001193125-26-201466
Officer· Chief Scientific Officer
Since Mar 2026
-1K
Net shares
Net seller
$157.0K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
1K disposed
Non-Derivative Transactions4
American depositary share
Direct
Shares
−42.00
Price / share
$155.68
Trade value
$6.54K
% of position
0.7%
4/30/2026
5.67K→5.62K
American depositary share
Direct
Shares
−517.00
Price / share
$156.59
Trade value
$80.96K
% of position
9.2%
4/30/2026
5.62K→5.11K
American depositary share
Direct
Shares
−340.00
Price / share
$157.37
Trade value
$53.51K
% of position
6.7%
4/30/2026
5.11K→4.77K
American depositary share
Direct
Shares
−101.00
Price / share
$158.15
Trade value
$15.97K
% of position
2.1%
4/30/2026
4.77K→4.67K
Total
Net shares
−1K
Net value
-$156.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 4/30/2026 | S · Sale | −42.00 | $155.68 | $6.54K | 0.7% | 5.67K | 5.62K |
| American depositary share Direct | 4/30/2026 | S · Sale | −517.00 | $156.59 | $80.96K | 9.2% | 5.62K | 5.11K |
| American depositary share Direct | 4/30/2026 | S · Sale | −340.00 | $157.37 | $53.51K | 6.7% | 5.11K | 4.77K |
| American depositary share Direct | 4/30/2026 | S · Sale | −101.00 | $158.15 | $15.97K | 2.1% | 4.77K | 4.67K |
| Total | −1K | -$156.97K | ||||||
Derivative Transactions0
No derivative transactions reported